Batavia Biosciences announces today that the International AIDS Vaccine Initiative (IAVI) and Batavia Biosciences will work together under a grant to advance the development of a Lassa fever vaccine.
Outbreak-focused Coalition for Epidemic Preparedness Innovations (CEPI) has already shelled out three times to support research on MERS and Lassa fever vaccines.